Australia and New Zealand Society of Nephrology Annual Scientific Conference

Session Details

Dialysis Poster Session 2

Wednesday, 16 August 2006 16:00 -17:30

Corryong 1&2

Co-Chair A/Prof Peter G Kerr Monash Medical CentreAustralia
Co-Chair A/Prof John Collins   

The Role of Nocturnal Haemodialysis and Arterial Stiffness
  • Michael Lian, Department of Nephrology, The Royal Melbourne Hospital, Australia
  • Outcomes Of Open Heart Surgery In Chronic Dialysis Patients
  • Michael Lian, Department of Nephrology, The Royal Melbourne Hospital, Australia
  • Measurement of Vascular Calcification from Computed Tomography Fistulograms
  • Dr Nigel D Toussaint, Department of Nephrology, Monash Medical Centre, Australia
  • Multi-slice CT Fistulography: a preliminary comparison to digital subtraction angiography
  • Dr Kevan R Polkinghorne, Department of Nephrology, Monash Medical Centre, VIC, Australia
  • Dialysis patients without known cardiovascular disease have high cardiovascular mortality: analysis of the ANZDATA Registry
  • Matthew A Roberts, Austin Health, Australia
  • A randomised trial of fish and fruit to improve survival of people on maintenance haemodialysis
  • Dr Paul Snelling, Renal Unit, Sydney South Western Area Health Service, Australia
  • Predicting future requirements for renal replacement therapy (RRT) in Australia
  • A/Prof Stephen P McDonald, ANZDATA Registry, Australia
  • Outcomes of a decontamination protocol for the treatment of tunnelled haemodialysis catheter related sepsis
  • Yanella Martinez, Renal Unit, St George Hospital, Sydney, Australia
  • Development of a national system of dialysis care standards and audit
  • Kelvin L Lynn, Christchurch Hospital, New Zealand
  • Successful use of a commercial Very Low Calorie Diet in a morbidly obese haemodialysis patient: A case report
  • Ms Kelly Lambert, Wollongong Hospital, Australia
  • The impact of a modified high-flux polysulfone (Helixone®) versus standard high-flux polysulfone dialysis membrane on inflammatory markers: A randomised single blinded controlled clinical trial
  • A/Prof Peter G Kerr, Monash Medical Centre, Australia
  • Intradermal hepatitis B vaccination in non-responsive and naïve dialysis patients
  • Clyson Mutatiri, Fremantle Hospital, Australia
  • Reduction Of Pulse Pressure By Intravenous N-Acetylcyseine Administration In Chronic Hemodialysis Patients
  • Mochammad Thaha, Department of Internal Medicine, Airlangga School of Medicine, Dr Soetomo Teaching Hospital, Surabaya, Indonesia
  • Nocturnal Home Haemodialysis Program – The Royal Brisbane experience
  • Dr Valli Manickam, Royal Brisbane and Women's Hospital, Australia
  • Nutritional Status and Appetite Regulation in Alternate Night Nocturnal Haemodialysis
  • Dr Carolyn L van Eps, Princess Alexandra Hospital, Australia
  • Is the Cardiovascular Risk Factor Visceral Fat Reduced in Nocturnal Dialysis?
  • Rebecca Pellicano, Monash Medical Centre, Australia
  • Improvements in Dialysis Clinical Indicators: Results of the Queensland Renal Collaborative
  • Dr Nicholas Gray, Nambour Hospital , Queensland, Australia
  • Bone Mineral Metabolism and Histology in Alternate Nightly Nocturnal Haemodialysis
  • Dr Carolyn L van Eps, Princess Alexandra Hospital, Australia
  • Left Ventricular Hypertrophy in Nocturnal Haemodialysis Patients
  • Carolyn J Clark, Barwon Health, Australia
  • Patterns of Infection in Nocturnal Haemodialysis Patients: an Observational Study
  • Carolyn J Clark, Barwon Health, Australia
  • Published on Monday, 31 July 2006 by the Professional Conference Organiser